{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:40:25Z","timestamp":1784774425991,"version":"3.55.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1097\/hjh.0000000000000076","type":"journal-article","created":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T11:07:36Z","timestamp":1390216056000},"page":"627-634","source":"Crossref","is-referenced-by-count":36,"title":["Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension"],"prefix":"10.1097","volume":"32","author":[{"given":"Chiara","family":"Lonati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Bassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gritti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Biganzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Morganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20210208","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","article-title":"A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.","volume":"141","author":"Hiramatsu","year":"1981","journal-title":"Arch Intern Med"},{"key":"R2-23-20210208","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/HJH.0b013e3282f4b3e6","article-title":"Primary aldosteronism: an update on screening, diagnosis and treatment.","volume":"26","author":"Rossi","year":"2008","journal-title":"J Hypertens"},{"key":"R3-23-20210208","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1097\/HJH.0b013e3283559a03","article-title":"Primary aldosteronism: evidence against a second epidemic.","volume":"30","author":"Kaplan","year":"2012","journal-title":"J Hypertens"},{"key":"R4-23-20210208","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1097\/HJH.0b013e328356c5be","article-title":"Ultimately we are in furious agreement.","volume":"30","author":"Funder","year":"2012","journal-title":"J Hypertens"},{"key":"R5-23-20210208","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1210\/jc.2009-1406","article-title":"Familial and phenotypic associations of the aldosterone renin ratio.","volume":"94","author":"Alvarez-Madrazo","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-23-20210208","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1210\/jc.2004-1149","article-title":"The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling.","volume":"90","author":"Tiu","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-23-20210208","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary hyperaldosteronism.","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R8-23-20210208","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism: results of the PAPY study.","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"key":"R9-23-20210208","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1097\/HJH.0b013e328359862d","article-title":"Association of elevated plasma aldosterone-to-renin ratio with future cardiovascular events in patients with essential hypertension.","volume":"30","author":"Kisaka","year":"2012","journal-title":"J Hypertens"},{"key":"R10-23-20210208","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1097\/HJH.0b013e32834bbc8a","article-title":"Association of plasma renin activity and aldosterone-renin ratio with prevalence of chronic kidney disease: the Kaiser Permanente Southern California cohort.","volume":"29","author":"Sim","year":"2011","journal-title":"J Hypertens"},{"key":"R11-23-20210208","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1097\/HJH.0b013e328354f65b","article-title":"Plasma renin activity and the aldosterone-to-renin ratio are associated with the development of chronic kidney disease: the Ohasama study.","volume":"30","author":"Terata","year":"2012","journal-title":"J Hypertens"},{"key":"R12-23-20210208","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00004872-200402000-00006","article-title":"The challenge of more robust and reproducible methodology in screening for primary aldosteronism.","volume":"22","author":"Gordon","year":"2004","journal-title":"J Hypertens"},{"key":"R13-23-20210208","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline.","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-23-20210208","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/07435809209035402","article-title":"Renal and adrenal responsiveness to angiotensin II: influence of -adrenergic blockade.","volume":"18","author":"Gordon","year":"1992","journal-title":"Endocr Res"},{"key":"R15-23-20210208","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11154-011-9163-7","article-title":"Commentary on the Endocrine Society Practice Guidelines: consequences of adjustment of antihypertensive medication in screening of primary aldosteronism.","volume":"12","author":"Fischer","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"key":"R16-23-20210208","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/HJH.0b013e32833857ad","article-title":"on behalf of the European study group for the validation of DiaSorin Liaison direct renin assay. A comparative study on inter and intralaboratory reproducibility of renin measurement with a conventional enzymatic method and a new chemiluminescent assay of immunoreactive renin.","volume":"28","author":"Morganti","year":"2010","journal-title":"J Hypertens"},{"key":"R17-23-20210208","first-page":"235","article-title":"A reevaluation of methodological aspects of a commercial RIA kit for plasma renin activity.","volume":"29","author":"Glorioso","year":"1985","journal-title":"J Nucl Med Allied Sci"},{"key":"R18-23-20210208","first-page":"257","article-title":"Analytical and clinical performance of an automated chemiluminescent immunoassay for direct renin measurement: comparison with PRA and aldosterone assays.","volume":"20","author":"Iervasi","year":"2005","journal-title":"Immunoanal Biol Special"},{"key":"R20-23-20210208","first-page":"709","article-title":"A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I.","volume":"21","author":"Passing","year":"1983","journal-title":"J Clin Chem Clin Biochem"},{"key":"R22-23-20210208","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00004872-200402000-00023","article-title":"Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism.","volume":"22","author":"Ferrari","year":"2004","journal-title":"J Hypertens"},{"key":"R23-23-20210208","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1373\/clinchem.2004.033159","article-title":"Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone-to-renin concentration determined by fully automated chemiluminescence immunoassays.","volume":"50","author":"Perschel","year":"2004","journal-title":"Clin Chem"},{"key":"R24-23-20210208","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1097\/HJH.0b013e32833d2192","article-title":"The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma.","volume":"28","author":"Rossi","year":"2010","journal-title":"J Hypertens"},{"key":"R25-23-20210208","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1258\/acb.2010.009230","article-title":"A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin.","volume":"47","author":"Dorrian","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"R26-23-20210208","first-page":"115","article-title":"Active mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism.","volume":"4","author":"Corbin","year":"2011","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"R27-23-20210208","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.acvd.2012.07.006","article-title":"Aldosterone-to-renin ratio for diagnosing aldosterone-producing adenoma: a multicentre study.","volume":"105","author":"Ducher","year":"2012","journal-title":"Arch Cardiovasc Dis"},{"key":"R28-23-20210208","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1530\/EJE-11-1013","article-title":"Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies.","volume":"167","author":"Hannemann","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"R29-23-20210208","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1055\/s-0032-1301894","article-title":"One-hour upright posture is an ideal position for serum aldosterone concentration and plasma renin activity measuring on primary aldosteronism screening.","volume":"120","author":"Yin","year":"2012","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R30-23-20210208","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/01.HYP.1.2.130","article-title":"The substitutive role of ACTH in supporting aldosterone response to head-up tilt during acute renin suppression in patients with essential hypertension.","volume":"1","author":"Morganti","year":"1979","journal-title":"Hypertension"},{"key":"R31-23-20210208","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ncpneph0575","article-title":"The incidence and implications of aldosterone breakthrough.","volume":"3","author":"Bomback","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"R32-23-20210208","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1210\/jc.2010-0225","article-title":"Effect of atenolol on aldosteronerenin ratio calculated by both plasma renin activity and direct renin concentration in healthy male volunteers.","volume":"95","author":"Ahmed","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R33-23-20210208","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1373\/clinchem.2004.033654","article-title":"Direct renin assay and plasma renin activity assay compared.","volume":"50","author":"Hartman","year":"2004","journal-title":"Clin Chem"},{"key":"R34-23-20210208","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","article-title":"Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio.","volume":"37","author":"Gallay","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"R35-23-20210208","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosteroneplasma renin activity ratio in primary aldosteronism.","volume":"40","author":"Mulatero","year":"2002","journal-title":"Hypertension"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HJH.0000000000000076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:02:43Z","timestamp":1620954163000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-201403000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0000000000000076","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}